PFM Health Sciences’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-50,809
| Closed | -$3.24M | – | 70 |
|
2025
Q1 | $3.24M | Sell |
50,809
-49,363
| -49% | -$3.15M | 0.24% | 45 |
|
2024
Q4 | $12.2M | Buy |
100,172
+11,956
| +14% | +$1.45M | 0.75% | 29 |
|
2024
Q3 | $11M | Hold |
88,216
| – | – | 0.62% | 36 |
|
2024
Q2 | $13.9M | Buy |
88,216
+76,925
| +681% | +$12.2M | 0.69% | 37 |
|
2024
Q1 | $1.46M | Buy |
+11,291
| New | +$1.46M | 0.07% | 81 |
|
2023
Q4 | – | Sell |
-250,967
| Closed | -$30.4M | – | 74 |
|
2023
Q3 | $30.4M | Buy |
250,967
+85,202
| +51% | +$10.3M | 1.43% | 31 |
|
2023
Q2 | $19M | Buy |
+165,765
| New | +$19M | 0.74% | 44 |
|
2019
Q3 | – | Sell |
-546,786
| Closed | -$83.1M | – | 97 |
|
2019
Q2 | $83.1M | Buy |
+546,786
| New | +$83.1M | 1.58% | 18 |
|
2018
Q4 | – | Sell |
-122,490
| Closed | -$19.8M | – | 119 |
|
2018
Q3 | $19.8M | Buy |
+122,490
| New | +$19.8M | 0.29% | 84 |
|